Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Addex Therapeutics Ltd
  6. Financials
    ADXN   CH0029850754

ADDEX THERAPEUTICS LTD

(ADXN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 59,343,453,266,9--
Entreprise Value (EV)1 59,312,134,572,289,8120
P/E ratio --2,93x-4,15x-3,57x-2,15x-1,67x
Yield ------
Capitalization / Revenue -15,7x13,7x41,5x55,4x37,2x
EV / Revenue -4,37x8,89x44,8x74,3x66,6x
EV / EBITDA --0,85x-2,91x-3,37x-3,67x-4,01x
Price to Book -1,71x3,69x-26,3x-1,90x-0,93x
Nbr of stocks (in thousands) 26 37226 48526 75443 584--
Reference price (CHF) 2,251,641,991,541,541,54
Announcement Date 04/30/201904/08/202003/11/2021---
1 CHF in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 -2,763,881,611,211,80
EBITDA1 --14,3-11,9-21,4-24,5-29,9
Operating profit (EBIT)1 --14,6-12,2-18,5-22,7-30,3
Operating Margin --529%-316%-1 148%-1 875%-1 683%
Pre-Tax Profit (EBT)1 --14,8-12,9-15,1-25,7-30,9
Net income1 -1,64-14,8-12,9-15,1-25,7-30,9
Net margin --535%-332%-935%-2 126%-1 717%
EPS2 --0,56-0,48-0,43-0,72-0,92
Dividend per Share2 ------
Announcement Date 04/30/201904/08/202003/11/2021---
1 CHF in Million
2 CHF
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4
Net sales1 0,920,240,080,08
EBITDA ----
Operating profit (EBIT)1 -3,15-3,89-4,17-4,29
Operating Margin -341%-1 650%-5 213%-5 363%
Pre-Tax Profit (EBT)1 -2,64-3,92-4,19-4,31
Net income1 -2,64-3,92-4,19-4,31
Net margin -286%-1 659%-5 239%-5 389%
EPS2 -0,08-0,12-0,12-0,11
Dividend per Share ----
Announcement Date 05/05/2021---
1 CHF in Million
2 CHF
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ---5,2822,953,0
Net Cash position1 -31,418,8---
Leverage (Debt / EBITDA) -2,20x1,58x-0,25x-0,93x-1,77x
Free Cash Flow1 --9,51-12,2-18,1-32,7-31,0
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share2 -0,960,54-0,06-0,81-1,65
Cash Flow per Share2 --0,36-0,46-0,62-0,57-
Capex1 --0,060,220,240,40
Capex / Sales --1,53%13,7%19,9%22,2%
Announcement Date 04/30/201904/08/202003/11/2021---
1 CHF in Million
2 CHF
Key data
Capitalization (CHF) 66 902 004
Capitalization (USD) 72 818 508
Net sales (CHF) 3 879 000
Net sales (USD) 4 223 067
Number of employees 27
Sales / Employee (CHF) 143 667
Sales / Employee (USD) 156 410
Free-Float 80,5%
Free-Float capitalization (CHF) 53 827 818
Free-Float capitalization (USD) 58 588 101
Avg. Exchange 20 sessions (CHF) 42 335
Avg. Exchange 20 sessions (USD) 46 090
Average Daily Capital Traded 0,06%
EPS & Dividend